date:Mar 12, 2013
ctions net of trade spend and new product volume.
Pet Products operating income declined 8.6% from $95.3 million in the prior year period to $87.1 million in the third quarter fiscal 2013. The decline was primarily driven by higher ingredient costs, costs associated with the voluntary recall noted previously and increased marketing investment. We realized positive list pricing actions net of trade spend as well as the positive impact of increased volume.
Pet Products Adjusted EBITDA increased